文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

诊断管理是临床微生物学的核心:法国微生物学会立场文件

Diagnostic stewardship as the heart of clinical microbiology: a position paper of the French Society for Microbiology (SFM).
PubMed 文献 · Clin Microbiol Infect · 2026-09-19

法国微生物学会发布立场文件,指出诊断管理是临床微生物学家的核心使命,而不仅仅是技术操作。文章强调实验室结果若缺乏解读可能助长不当抗生素使用,呼吁将微生物学家重新定位为主动的临床参与者,并提出个体、实验室和国家层面的具体行动。

要点

  • 诊断管理是临床微生物学家的核心使命,超越抗菌药物管理范畴。
  • 未解读的检验结果非中性,易导致抗生素不当使用。
  • 主要障碍是结构性:按检测量计费使解读工作无回报。

核心结论

  • 诊断管理应被视为临床微生物学的核心使命,微生物学家需从被动提供结果转为主动临床参与者。

研究设计与样本

  • 法国微生物学会(SFM)发布的立场文件,讨论诊断管理在临床微生物学中的角色与实施障碍。

主要发现

  • 诊断管理挑战具有普遍性,范围远超出抗菌药物使用,涵盖病毒学、真菌学、暴发管理、筛查项目和感染预防控制。
  • 微生物学家临床参与时间日益减少,而实验室结果若缺乏解读易被误用,成为抗生素处方的未识别驱动因素。
  • 主要障碍是结构性的:当实验室活动按检测量衡量和资助时,将结果转化为合理医疗决策的解读工作得不到回报。

关键数值与推荐

  • 提出在个体、实验室和国家层面采取具体行动,并可适应本地情况推广到其他环境。
  • 强调这些原则同样适用于社区环境,尽管文件聚焦医院实践。

临床怎么用

  • 临床微生物学家应主动参与结果解读,避免检验结果被误用。
  • 在个体、实验室和国家层面推动诊断管理行动,并根据本地情境调整。
  • 倡导改变按检测量资助实验室的模式,以认可解读工作的价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Caring about the clinical impact of laboratory results, beyond their technical performance, has been part of the clinical microbiologist's mission since the very origins of the discipline. The term diagnostic stewardship is more recent, emerging from a renewed need created by powerful new diagnostic technologies: as testing becomes faster, more sensitive and more widely used, results grow harder to interpret and easier to misuse. A result reported without interpretation is not neutral, and diagnostic misuse readily translates into inappropriate antibiotic use, making the laboratory an unrecognised driver of antibiotic prescription, while microbiologists have ever less time for clinical engagement. Diagnostic stewardship is thus a universal challenge, with a scope that extends well beyond antimicrobial use to virology, mycology, outbreak management, screening programmes and infection prevention and control. In this position statement, the French Society for Microbiology argues that diagnostic stewardship is a core mission of clinical microbiologists and calls for the microbiologist to be repositioned as an active clinical actor rather than a passive provider of results. We discuss how this role varies across healthcare systems, notably between the United States and Europe. We propose concrete actions at the individual, laboratory and national levels. These actions are generalizable to other settings, provided they are adapted to the local context. We argue that the main obstacle is structural: when laboratory activity is measured and funded by test volume, the interpretive work that turns results into sound medical decisions goes unrewarded. While we focus on hospital practice, these principles apply equally to community settings. Recognizing and supporting this distinctive clinical role of microbiologists is now essential.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Mizrahi A, Burucoa C, Le Goff J, et al. Diagnostic stewardship as the heart of clinical microbiology: a position paper of the French Society for Microbiology (SFM). Clin Microbiol Infect. 2026. PMID: 42763036. doi:10.1016/j.cmi.2026.09.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。